HOKUTO CORPORATION FY2027 Q1 Earnings Report

Quick View

Executive Summary

Although Revenue increased and both Operating Income and Ordinary Income rose, Net Income declined significantly due to the absence of the previous year’s extraordinary gains. Revenue was ¥193.4B (+4.4% YoY), Operating Income was ¥4.2B (+136.8% YoY), and Ordinary Income was ¥7.8B (+426.1% YoY), supported by non-operating income from dividend income and foreign exchange gains. Meanwhile, Net Income was ¥4.5B (-66.7% YoY), primarily due to the reversal of the previous year’s ¥18.98B in extraordinary gains, including insurance proceeds, as well as the high tax burden reflected in an effective tax rate of 41.9%.

Factors Affecting Results

【Revenue】Revenue was ¥193.4B (+4.4% YoY). The Domestic Mushroom Business maintained its leading position, accounting for 61.1% of Revenue at ¥121.4B (+2.7%), while the Chemical Products Business recorded the highest growth at ¥41.2B (+16.3%). The Processed Products Business was ¥17.8B (+6.3%), and the Overseas Mushroom Business was ¥18.2B (-0.1%), essentially flat.

【Profit and Loss】Gross profit was ¥46.5B, with the gross margin improving to 24.0% (+0.4pt YoY). Selling, general and administrative expenses were ¥42.3B, representing an SG&A ratio of 21.9%, and growth remained below Revenue growth. As a result, Operating Income increased significantly to ¥4.2B (+136.8%). Ordinary Income expanded to ¥7.8B (+426.1%), supported by ¥4.0B in non-operating income, including ¥2.0B in dividend income and ¥1.1B in foreign exchange gains. However, Net Income declined to ¥4.5B (-66.7%) due to the absence of the previous year’s extraordinary gains, including ¥18.98B in insurance proceeds, and the high tax burden. Overall, the Company achieved higher Revenue and higher profit at the Operating Income and Ordinary Income levels, but Net Income declined due to the reversal of temporary factors.

Segment Analysis

By segment, the Domestic Mushroom Business was the largest driver of profit growth, with Operating Income of ¥6.7B (+47.6% YoY; profit margin of 5.5%). The Chemical Products Business also grew to ¥1.9B (+75.7%; profit margin of 4.6%). In contrast, the Overseas Mushroom Business recorded a sharp decline in profit to ¥0.8B (-64.5%; profit margin of 4.5%), suggesting the impact of higher costs and local market conditions. The Processed Products Business improved to ¥0.4B (+143.8%; profit margin of 2.2%), although it remained at a low level. The recovery of the domestic core business and growth in chemical products supported company-wide profit growth, while deteriorating profitability in the overseas business widened the disparity among segments.

Key Financial Indicators

【Profitability】The Operating Income margin improved to 2.2% from 0.95% in the previous year, although the absolute level remained low. The Net Income margin declined significantly to 2.3% from 7.3% in the previous year due to the absence of extraordinary gains. ROE was 0.7%, indicating that capital efficiency remained low. 【Cash Flow Quality】Non-operating income accounted for approximately 52% of Ordinary Income (¥4.0B/¥7.8B), indicating a high degree of dependence on dividend income and foreign exchange gains. 【Investment Efficiency】The Equity Ratio declined slightly to 55.7% from 57.1% in the previous year. Total assets were ¥1157.3B and net assets were ¥645.0B, both essentially flat from the previous year. 【Financial Soundness】Cash and deposits were substantial at ¥219.8B, a level sufficient to cover the increase in short-term borrowings (+71.0% YoY).

Cash Flow Analysis

Although cash flow statement data were not disclosed, an analysis of funding trends based on changes in the balance sheet indicates that cash and deposits increased to ¥219.8B (+17.3% YoY), while short-term borrowings also increased significantly to ¥96.4B (+71.0% YoY). This suggests increased funding needs associated with the accumulation of working capital, including inventories and notes receivable. Investment securities were maintained at approximately ¥114.5B (+3.7%), with no significant asset replacement activity observed. Cash increased at a faster pace than short-term borrowings, providing a buffer for near-term liquidity management.

Earnings Quality

Extraordinary gains in the current period were minimal at ¥0.02B. The primary reason for the decline in Net Income was the absence of the ¥18.98B in extraordinary gains recognized in the previous year, including insurance proceeds. Of Ordinary Income of ¥7.8B, non-operating income accounted for ¥4.0B, comprising ¥2.0B in dividend income and ¥1.1B in foreign exchange gains. Its approximately 52% share warrants attention when evaluating earnings quality, as it indicates a significant contribution from non-operating income and expenses relative to core Operating Income. The gap between Ordinary Income and Net Income was attributable to the high tax burden, reflected in an effective tax rate of 41.9%. Fluctuations in non-operating factors and the tax rate amplified volatility in Net Income. Comprehensive income was ¥9.7B, exceeding Net Income of ¥4.5B, supported by ¥3.8B in valuation differences on securities and ¥1.5B in foreign currency translation adjustments.

Earnings Forecast and Guidance

Q1 progress against the full-year plan—Revenue of ¥881.0B, Operating Income of ¥72.6B, and Ordinary Income of ¥76.5B—was 21.9% for Revenue, 5.8% for Operating Income, 10.2% for Ordinary Income, and 8.6% for Net Income (¥4.5B against the full-year Net Income forecast of ¥52.5B). Compared with the standard quarterly progress rate of 25%, progress for Operating Income in particular was substantially below plan. Possible factors include seasonality resulting in a back-loaded second half, the cost structure in the first half, and deteriorating profitability in the Overseas Mushroom Business. Neither the earnings forecast nor the dividend forecast has been revised, and the Company has maintained its full-year plan.

Shareholder Returns

The full-year dividend forecast is ¥62 annually, resulting in a Payout Ratio of approximately 37.1% against the full-year EPS forecast of ¥167.22. Actual EPS for Q1 was ¥14.44, a significant decrease from ¥43.43 in the previous year, due to the absence of extraordinary gains; the dividend plan itself remains unchanged. Supported by cash and deposits of ¥219.8B and conservative financial leverage, the Company has sufficient capacity to maintain dividends for the foreseeable future. No share repurchases have been disclosed, and shareholder returns consist solely of dividends.

Risk Factors

1. Deteriorating profitability in the Overseas Mushroom Business: Revenue was essentially flat (-0.1%), while Operating Income declined to ¥0.8B, down -64.5% YoY, and the profit margin also deteriorated. Continued foreign exchange volatility or increases in local costs could weigh on company-wide margins.

2. Increase in short-term borrowings and refinancing sensitivity: Short-term borrowings increased to ¥96.4B, up +71.0% YoY, increasing their share of current liabilities. Although cash of ¥219.8B provides a cushion, the impact on the funding structure warrants monitoring if inventories and receivables remain elevated.

3. High tax burden and dependence on temporary factors in the earnings structure: The effective tax rate was high at 41.9%, while approximately 52% of Ordinary Income consisted of non-operating income, including dividend income and foreign exchange gains. These factors are susceptible to market conditions, making the accumulation of core Operating Income important for the stability of the earnings base.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (bank)

Profitability and Returns

Median data are insufficient, limiting relative assessment based solely on the Company’s levels.

Growth and Capital Efficiency

There are also no industry median data for the Revenue growth rate, limiting comparability.

※Source: Compiled by the Company

Key Points from the Earnings Results

1. Although higher Revenue and higher profit at the Operating Income and Ordinary Income levels were confirmed, Net Income declined significantly due to the absence of the previous year’s extraordinary gains, including insurance proceeds, and the high tax burden. It is therefore necessary to distinguish between improvement at the operating level and the trend in Net Income.

2. By segment, the Domestic Mushroom Business and Chemical Products Business drove profit growth, while deteriorating profitability in the Overseas Mushroom Business restrained the improvement in company-wide profitability.

3. Q1 progress against the full-year plan was low at 5.8% for Operating Income. Whether the plan’s assumption of a back-loaded second half will be achieved should be monitored in subsequent earnings results.

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. Industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, in consultation with a professional as necessary.

---End of Report---